KCT0000389招募中未知
mbilical cord blood-derived mesenchymal stem cells for the treatment of steroid-refractory acute or chronic graft-versus-host-disease
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 0(Year) 至 30(Year)（—）
- 性别
- All
入选标准
- •1. Steroid-refractory acute or chronic graft-versus-host-disease
- •2. Acquisition of consent form
- •3. 0-30 years of age
排除标准
- •1. Withdrawal from the study
- •2. Progression of underlying hematologic diseases
- •3. Severe adverse effects related to the investigational drug
研究者
相似试验
已完成
1 期
mbilical cord-derived mesenchymal stromal cells therapy for SARS-CoV-2 infection (COVID-19) related Acute Respiratory Distress SyndromeJPRN-jRCT1080225369Human Life CORD Japan Inc.12
进行中（未招募）
1 期
The use of mesenchymal stem cells from the bone marrow stroma for reconstruction of the anterior cruciate ligamentEUCTR2020-002732-75-PLAlexander IV sp. Partnership Ortopedika Surgery Specialistic Center12
已完成
不适用
Bone marrow derived mesenchymal stem cells for the treatment of allograft rejection after renal transplantatioaandoeningen na niertransplantatieallograft rejectionrejection after (renal) transplantation10038430NL-OMON31649eids Universitair Medisch Centrum15
进行中（未招募）
1 期
Safety of bone marrow-derived stem cells in treatment of knee cartilage defects.EUCTR2018-004067-31-CZBioinova, s.r.o.6
尚未招募
1 期
Transplantation of stem cells for the treatment of type 1 diabetes.Type 1 diabetes mellitus (T1DM).Type 1 diabetes mellitusIRCT20210925052566N1Endocrinology and Metabolism Research Institute30